Daniel Antunes Moreno

670 total citations
34 papers, 461 citations indexed

About

Daniel Antunes Moreno is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Antunes Moreno has authored 34 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 13 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Antunes Moreno's work include Glioma Diagnosis and Treatment (16 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Acute Myeloid Leukemia Research (5 papers). Daniel Antunes Moreno is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Acute Myeloid Leukemia Research (5 papers). Daniel Antunes Moreno collaborates with scholars based in Brazil, Portugal and United States. Daniel Antunes Moreno's co-authors include Carlos Alberto Scrideli, Luíz Gonzaga Tone, Vanessa S. Silveira, José Andrés Yunes, Sílvia Regina Brandalise, Elvis Terci Valera, Kleiton Silva Borges, Carlos Gilberto Carlotti, Harley Francisco de Oliveira and Rosane Gomes de Paula Queiróz and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Daniel Antunes Moreno

33 papers receiving 458 citations

Peers

Countries citing papers authored by Daniel Antunes Moreno

Since Specialization

Citations

This map shows the geographic impact of Daniel Antunes Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Antunes Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Antunes Moreno more than expected).

Fields of papers citing papers by Daniel Antunes Moreno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Antunes Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Antunes Moreno. The network helps show where Daniel Antunes Moreno may publish in the future.

Co-authorship network of co-authors of Daniel Antunes Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Antunes Moreno. A scholar is included among the top collaborators of Daniel Antunes Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Antunes Moreno. Daniel Antunes Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune profiling of pediatric germ cell tumors identifies key cell populations and novel therapeutic targets 2025 ·Frontiers in Immunology ·(unknown), (unknown), Mabel Cruz, (unknown), (unknown), (unknown), Luiz Fernando Lopes, Rui Manuel Reis, Daniel Antunes Moreno, (unknown)	0
2	Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator SLUG 2024 ·Molecular Medicine Reports ·(unknown), Marcela N. Rosa, Daniel Antunes Moreno, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), André van Helvoort Lengert, (unknown), (unknown), Rui Manuel Reis, Luiz Fernando Lopes, (unknown)	1
3	Somatic mutational profiling and clinical impact of driver genes in Latin‐Iberian medulloblastomas: Towards precision medicine 2024 ·Neuropathology ·(unknown), (unknown), Mariana Bisarro dos Reis, Flávia Escremim de Paula, (unknown), Daniel Antunes Moreno, (unknown), Iara Viana Vidigal Santana, Fabiano Pinto Saggioro, Luciano Neder, João Norberto Stávale, Suzana Mária Fleury Malheiros, Hernán Garcı́a Rivello, Silvia Christiansen, (unknown), (unknown), Jorge Pinheiro, (unknown), (unknown), Rui Manuel Reis	1
4	Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis 2024 ·World Neurosurgery ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Raphael Bertani, Daniel Antunes Moreno, (unknown)	4
5	Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing 2023 ·Molecular Case Studies ·(unknown), Adriane Feijó Evangelista, (unknown), Daniel Antunes Moreno, Gustavo Nóriz Berardinelli, Flávia Escremim de Paula, (unknown), (unknown), (unknown), Iara Viana Vidigal Santana, (unknown), (unknown), Rui Manuel Reis	2
6	Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets 2023 ·Frontiers in Immunology ·(unknown), Daniel Antunes Moreno, (unknown), Letícia Ferro Leal, Flávia Escremim de Paula, Iara Viana Vidigal Santana, (unknown), Fabiano Pinto Saggioro, Luciano Neder, (unknown), (unknown), Rui Manuel Reis	16
7	USP15-USP7 Axis and UBE2T Differential Expression May Predict Pathogenesis and Poor Prognosis in De Novo Myelodysplastic Neoplasm 2023 ·International Journal of Molecular Sciences ·(unknown), Tatiana Takahasi Komoto, Daniel Antunes Moreno, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ronald Feitosa Pinheiro, Howard Lopes Ribeiro	5
8	Extremely aggressive course in a poorly differentiated thyroid carcinoma presenting a double mutation of the TERT promoter 2023 ·The American Journal of the Medical Sciences ·Denise Engelbrecht Zantut‐Wittmann, (unknown), Daniel Antunes Moreno, (unknown), (unknown), (unknown), (unknown), (unknown), Rui Manuel Reis	1
9	Panobinostat (LBH589) increase survival in adult xenografic model of acute lymphoblastic leukemia with t(4;11) but promotes antagonistic effects in combination with MTX and 6MP 2022 ·Medical Oncology ·Daniel Antunes Moreno, Howard Lopes Ribeiro, Angelo B. A. Laranjeira, (unknown), Kleiton Silva Borges, (unknown), Fernando Silva Ramalho, José Andrés Yunes, (unknown), Eduardo Magalhães Rego, Carlos Alberto Scrideli, Luíz Gonzaga Tone	6
10	Indisulam Reduces Viability and Regulates Apoptotic Gene Expression in Pediatric High-Grade Glioma Cells 2022 ·Biomedicines ·(unknown), Carlos Alberto Scrideli, Augusto Faria Andrade, Mariano S. Viapiano, Carlos Gilberto Carlotti, Daniel Antunes Moreno, (unknown), Luíz Gonzaga Tone, (unknown)	7
11	NTRK2 gene fusions are uncommon in pilocytic astrocytoma 2022 ·Molecular Biology Reports ·Daniel Antunes Moreno, Aline Paixão Becker, Cristovam Scapulatempo‐Neto, (unknown), Jamie Sheren, (unknown), Carlos Clara, Hélio Rubens Machado, Ricardo Santos de Oliveira, Luciano Neder, Marileila Varella‐Garcia, Rui Manuel Reis	1
12	Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide 2021 ·Journal of Neuro-Oncology ·(unknown), Daniel Antunes Moreno, Mariana Bisarro dos Reis, Luciane Sussuchi da Silva, Letícia Ferro Leal, (unknown), (unknown), Marco Antônio de Oliveira, Marcus Matsushita, Rui Manuel Reis	15
13	Capnocytophaga canimorsus Aortitis in an Immunocompetent Host. 2020 ·PubMed ·(unknown), Daniel Antunes Moreno, (unknown)	3
14	Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients 2019 ·Molecular Biology Reports ·Marta Viana‐Pereira, Daniel Antunes Moreno, Paulo Linhares, (unknown), (unknown), Sandra Costa, Ruí Vaz, Rui Manuel Reis	10
15	Zebularine induces chemosensitization to methotrexate and efficiently decreases AhR gene methylation in childhood acute lymphoblastic leukemia cells 2013 ·Anti-Cancer Drugs ·Augusto Faria Andrade, Kleiton Silva Borges, (unknown), Vanessa S. Silveira, (unknown), Jaqueline Carvalho de Oliveira, Daniel Antunes Moreno, Rosane Gomes de Paula Queiróz, Carlos Alberto Scrideli, Luíz Gonzaga Tone	27
16	Expression profile of apoptosis-related genes in childhood adrenocortical tumors: low level of expression of BCL2 and TNF genes suggests a poor prognosis 2012 ·European Journal of Endocrinology ·(unknown), Daniel Antunes Moreno, Kleiton Silva Borges, Carlos Eduardo Martinelli, Sonir Roberto Rauber Antonini, Margaret de Castro, Sílvio Tucci, Luciano Neder, Leandra Náira Zambelli Ramalho, Izilda Aparecida Cardinalli, Ana Luíza Seidinger, Maria José Mastellaro, José Andrés Yunes, Sílvia Regina Brandalise, Luíz Gonzaga Tone, Carlos Alberto Scrideli	15
17	Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells 2011 ·Journal of Cancer Research and Clinical Oncology ·Kleiton Silva Borges, (unknown), Daniel Antunes Moreno, Vanessa S. Silveira, María Sol Brassesco, Rosane Gomes de Paula Queiróz, Harley Francisco de Oliveira, Carlos Gilberto Carlotti, Carlos Alberto Scrideli, Luíz Gonzaga Tone	43
18	A study of adrenocortical tumors in children and adolescents by a comparative genomic hybridization technique 2011 ·Cancer Genetics ·Elvis C. Mateo, (unknown), (unknown), Daniel Antunes Moreno, Luciano Neder, Sílvio Tucci, (unknown), Luíz Gonzaga Tone	2
19	research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia 2010 ·British Journal of Haematology ·Daniel Antunes Moreno, Carlos Alberto Scrideli, (unknown), (unknown), Elvis Terci Valera, Vanessa S. Silveira, José Andrés Yunes, Sílvia Regina Brandalise, Luíz Gonzaga Tone	152
20	ESTUDIO DEL PERFIL LIPÍDICO EN SUJETOS CON DIABETES MELLITUS TIPO 2 DE BOGOTÁ 2005 ·SHILAP Revista de lepidopterología ·Mauricio J. Ávila, (unknown), (unknown), Daniel Antunes Moreno, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact